Clinical Trial

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated May 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-29; most recent amendment 2025-08-06.
Status change: Not Yet Recruiting → Recruiting 2024-12-11
Trial Details
NCT Number NCT06666491
Lead Sponsor GlaxoSmithKline
Conditions Malaria, Vivax
Enrollment 300 participants
Start Date 2024-11-13
Primary Completion 2026-05-25 (estimated)
Study Completion 2026-05-25 (estimated)
Updated on ClinicalTrials.gov 2025-08-07